<?xml version="1.0" encoding="UTF-8"?>
<ref id="b19-1040710">
 <label>19.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nitti</surname>
    <given-names>VW</given-names>
   </name>
   <name>
    <surname>Auerbach</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Martin</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Calhoun</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Herschorn</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <article-title>Results of a randomized phase III trial of mirabegron in patients with overactive bladder</article-title>. 
  <source>J Urol</source>. 
  <year>2013</year>;
  <volume>189</volume>(
  <issue>4</issue>):
  <fpage>1388</fpage>â€“
  <lpage>1395</lpage>.
  <pub-id pub-id-type="pmid">23079373</pub-id>
 </mixed-citation>
</ref>
